PHOENIX–(BUSINESS WIRE)– #Arizona–Virginia G. Piper Charitable Trust has appointed Laura Smith as the new director of Eyes On Learning, a coalition of state, local, and national organizations dedicated to improving the vision health of Arizona’s chi…
Category: Business
Virginia G. Piper Charitable Trust Names Laura Smith as Director of Eyes On Learning
PHOENIX–(BUSINESS WIRE)– #Arizona–Virginia G. Piper Charitable Trust has appointed Laura Smith as the new director of Eyes On Learning, a coalition of state, local, and national organizations dedicated to improving the vision health of Arizona’s chi…
Samenvatting: Biocytogen en Nanjing Chia Tai Tianqing kondigen IND-goedkeuring aan in China voor het gezamenlijk ontwikkelde anti-IGF-1R antilichaam NTB003 (BCG009)
BEIJING & NANJING, China–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) en Nanjing Chia Tai Tianqing Pharmaceutical Co. Ltd. (“NJCTTQ”) hebben bekendgemaakt dat voor hun gezamenlijk ontwikkelde injecteerbar…
Biocytogen et Nanjing Chia Tai Tianqing annoncent l’autorisation IND en Chine pour l’anticorps anti-IGF-1R NTB003 (BCG009) développé conjointement
PÉKIN et NANJING, Chine–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Pékin) Co., Ltd. (« Biocytogen », HKEX : 02315) et Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (« NJCTTQ ») ont annoncé que le NTB003 (anciennement BCG009), un candidat médica…
Resumen: Biocytogen y Nanjing Chia Tai Tianqing anuncian aprobación IND en China para el anticuerpo NTB003 (BCG009) desarrollado conjuntamente contra el IGF-1R
BEIJING y NANJING, China–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Pekín) Co. Ltd. (“Biocytogen”, HKEX: 02315) y Nanjing Chia Tai Tianqing Pharmaceutical Co. Ltd. (“NJCTTQ”) anunciaron que NTB003 (ex BCG009), un candidato a fármaco inyectable desar…
Riassunto: Biocytogen e Nanjing Chia Tai Tianqing annunciano l'approvazione IND in Cina per l'anticorpo anti-IGF-1R NTB003 (BCG009) sviluppato congiuntamente
BEIJING e NANJING, Cina–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) e Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“NJCTTQ”) hanno annunciato che NTB003 (formerly BCG009), un farmaco candidato ini…
Biocytogen und Nanjing Chia Tai Tianqing geben IND-Zulassung in China für gemeinsam entwickelten Anti-IGF-1R-Antikörper NTB003 (BCG009) bekannt
BEIJING und NANJING, China–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. („Biocytogen“, HKEX: 02315) und Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. („NJCTTQ“) melden, dass NTB003 (zuvor BCG009), ein gemeinsam entwickelter, in…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Eye Health America Expands in Northeast Florida with the Addition of Schneider Eye & Wellness Center in Jacksonville Beach
JACKSONVILLE BEACH, Fla.–(BUSINESS WIRE)– #EyeCare–Eye Health America (EHA), a leading integrated eye care platform in the Southeastern United States, is proud to announce its newest partnership with Schneider Eye & Wellness Center, a respected …
Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia
LONDON & SEATTLE–(BUSINESS WIRE)– #BRIMOCHOL–Tenpoint Therapeutics Ltd. announces FDA acceptance of New Drug Application for BRIMOCHOL™ PF for the treatment of presbyopia
Warby Parker Announces Participation in the Baird Global Consumer, Technology & Services Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Baird Global Consumer, Technology & Services Confe…
Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
GENEVA–(BUSINESS WIRE)–Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
GENEVA–(BUSINESS WIRE)–Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
FDA Approves Genentech’s Susvimo for Diabetic Retinopathy
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment…
Europa Eyewear Appoints Megan Molony as Chief Executive Officer
CHICAGO–(BUSINESS WIRE)–Europa, a leading designer and manufacturer of premium independent eyewear, proudly announces the appointment of Megan Molony as its new chief executive officer, effective June 16. Molony will oversee the full Europa platform,…
Alfred E. Mann Charities Gives $12 Million for Cell and Gene Therapy Research at Children’s Hospital Los Angeles
LOS ANGELES–(BUSINESS WIRE)–Alfred E. Mann Charities has made a generous gift of $12 million to establish the Alfred E. Mann Cell and Gene Therapy Research Endowment and the Alfred E. Mann Cell and Gene Therapy Research Fund at Children’s Hospital Lo…
Warby Parker Partners with Google To Develop Intelligent Eyewear
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced a partnership with Google to develop AI-powered glasses intended for all-day wear. The partnershi…
Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced positive l…
STAAR Surgical Announces $30 Million Share Repurchase Authorization
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors has authoriz…